The inhibition of TNF-α-induced NF-κB activation by marine natural products

Biochemical Pharmacology

Volumn 78, Issue 6, 2009, Pages 592-606

  Folmer, Florence ^a   Jaspars, Marcel ^a   Solano, Godofredo ^a   Cristofanon, Silvia ^b   Henry, Estelle ^b   Tabudravu, Jioji ^a   Black, Kenny ^c   Green, David H ^c   Küpper, Frithjof C ^c   Aalbersberg, William ^d   Feussner, Klaus ^d   Dicato, Mario ^b   Diederich, Marc ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

^c SCOTTISH MARINE INSTITUTE   (United Kingdom)

^d UNIVERSITY OF THE SOUTH PACIFIC   (Fiji)

Author keywords

Anti cancer drug discovery; Marine natural product; NF B

Indexed keywords

3,4 EPOXY 13 OXO 15 CEMBRATRIENE; 6 METHOXYCOMAPARVIN; ASTAXANTHIN; I KAPPA B ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JASPAMIDE; NATURAL PRODUCT; PROTEIN P50; STELLETTIN A; STELLETTIN B; STELLIFERIN RIBOSIDE; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN K 562; COMANTHUS PARVICIRRUS; CONTROLLED STUDY; CORAL; CYTOTOXICITY; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIPID COMPOSITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RHABDASTRELLA GLOBOSTELLATA; SARCOPHYTON; SINULARIA; SPONGE (PORIFERA); SUBERGORGIA;

BIOLOGICAL PRODUCTS; CELL LINE, TUMOR; HUMANS; I-KAPPA B PROTEINS; MARINE BIOLOGY; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67749109784     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.05.009     Document Type: Article

References (87)

1. Garcia-Pineres A.J., Lindenmeyer M.T., and Merfort I. Role of cysteine residues of p65/NF-kappa B on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactivating potential. Life Sciences 75 (2004) 841-856
2. Mayo M.W., and Baldwin A.S. The transcription factor NF-kappa B: control of oncogenesis and cancer therapy resistance. Biochimica et Biophysica Acta-Reviews on Cancer 1470 (2000) M55-M62
3. Soysa N.S., and Alles N. NF-κB functions in osteoclasts. Biochemical and Biophysical Research Communications 378 (2009) 1-5
4. Baud V., and Karin M. Is NF-κB a good target for cancer therapy? Hopes and pitfalls. Nature Reviews Drug Discovery 8 (2009) 33-40
5. Ghosh S., and Hayden M.S. New regulators of NF-κB in inflammation. Nature Reviews Immunology 8 (2008) 837-848
6. Ocio E., Mateos M.V., Maiso P., Pandiella A., and San-Miguel J.F. New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings. Lancet 9 (2008) 1157-1165
7. Sakar F., and Li Y. NF-κB: a potential target for cancer chemoprevention and therapy. Frontiers in Bioscience 13 (2008) 2950-2959
8. Aggarwal B.B., Takada Y., Shishodia S., Gutierrez A.M., Oommen O.V., Ichikawa H., et al. Nuclear transcription factor NF-kappa B: role in biology and medicine. Indian Journal of Experimental Biology 42 (2004) 341-353
9. Karin M. Nuclear factor-kB in cancer development and progression. Nature 441 (2006) 431-436
10. Senftleben U., and Karin M. The IKK/NF-kappa B pathway. Critical Care Medicine 30 (2002) S18-S26
11. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (2004) 461-466
12. Luo J.L., Kamata H., and Karin M. IKK/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy. Journal of Clinical Investigation 115 (2005) 2625-2632
13. Karin M., Yamamoto Y., and Wang Q.M. The IKK NF-kappa B system: a treasure trove for drug development. Nature Reviews Drug Discovery 3 (2004) 17-26
14. Garg A., and Aggarwal B.B. Nuclear transcription factor-kappa B as a target for cancer drug development. Leukemia 16 (2002) 1053-1068
15. Pande V., Sharma R.K., Inoue J.I., Otsuka M., and Ramos M.J. A molecular modeling study of inhibitors of nuclear factor kappa-B (p50)-DNA binding. Journal of Computer-Aided Molecular Design 17 (2003) 825-836
16. Sun Z.W., and Andersson R. NF-kappa b activation and inhibition: a review. Shock 18 (2002) 99-106
17. Blonska M., Shameshakar P., Kobayashi M., Zhang D., Sakurai H., Su B., et al. TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappa B activation. Journal of Biological Chemistry 280 (2005) 43056-43063
18. Shim J., Changchun X., Paschal A., Bailey S., Rao P., Hayden M.S., et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes & Development 19 (2005) 2668-2681
19. Baud V., and Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends in Cell Biology 11 (2001) 372-377
20. Folmer F., Jaspars M., and Diederich M. Marine natural products as targeted modulators of the transcription factor NF-κB. Biochemical Pharmacology 75 (2008) 603-617
21. Bremner P., and Heinrich M. Natural products as targeted modulators of the nuclear factor-kappa B pathway. Journal of Pharmacy and Pharmacology 54 (2002) 453-472
22. Zambre A.P., Kulkarni V., Padhye S., Sandur S.K., and Aggarwal B.B. Curcumin analogs targeting TNF-induced NF-κB activation and proliferation in human leukemic KBM-5 cells. Bioorganic and Medicinal Chemistry 14 (2006) 7196-7204
23. Amigo M., Paya M., Braza-Boïls A., De Rosa M., and Terencio M.C. Avarol inhibits TNF-alpha generation of NF-kappaB activation in human cells and in animal models. Life Sciences 82 (2008) 256-264
24. Ahn K.S., Sethi G., Chao T.H., Neuteboom S.T., Chaturvedi M.M., Palladino M.A., et al. Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF-κB-regulated gene products. Blood 110 (2007) 2286-2295
25. Jensen P.R., Mincer T.J., Williams P.G., and Fenical W. Marine actinomycete diversity and natural product discovery. Antonie Van Leeuwenhoek 87 (2005) 43-48
26. Kobayashi J., and Ishibashi M. Bioactive metabolites of symbiotic marine microorganisms. Chemical Reviews 93 (1993) 1753-1769
27. Blunt J.W., Copp B.R., Munro M.H., Northcote P.T., and Prinsep M.R. Marine natural products. Natural Product Reports 23 (2006) 26-78
28. Jaspars M., and Lawton L. Cyanobacteria-a novel source of pharmaceuticals. Currrent Opinions on Drug Discovery and Development 1 (1998) 77-84
29. Cardozo K.H., Guaratini T., Barros M.P., Falcao V.R., Tonon A.P., Lopes N.P., et al. Metabolites from algae with economical impact. Comparative Biochemistry and Physiology C: Toxicology & Pharmacology 29 (2006) 29
30. Naguib Y.M. Antioxidant activities of astaxanthin and related carotenoids. Journal of Agricultural and Food Chemistry 48 (2000) 1150-1154
31. Misawa N., Satomi Y., Kondo K., Yokoyama A., Kajiwara A., Saito T., et al. Structure and functional analysis of a marine bacterial carotenoid biosynthesis gene cluster and astaxanthin biosynthetic pathway proposed at the gene level. Journal of Bacteriology 177 (1995) 6575-6584
32. Berge J.P., and Barnathan G. Fatty acids from lipids of marine organisms: molecular biodiversity, roles as biomarkers, biologically active compounds, and economical aspects. Advances in Biochemical Engineering and Biotechnology 96 (2005) 49-125
33. Patnayak S., and Sree A. Screening of bacterial associates of marine sponges for single cell oil and PUFA. Letters on Applied Microbiology 40 (2005) 358-363
34. Zhukova N.V., and Aizdaicher N.A. Fatty acid composition of 15 species of marine microalgae. Phytochemistry 39 (1995) 351-356
35. Folmer F., Harrison W., Tabudravu J., Jaspars M., Aalbersberg W., Feussner K., et al. NF-κB inhibiting naphthopyrones from the Fijian echinoderm Comanthus parvicirrus. Journal of Natural Products 71 (2008) 106-111
36. Pearson W.R. Rapid and sensitive sequence comparison with FASTP and FASTA. Methods in Enzymology 183 (1990) 63-98
37. Christie W. Preparation of ester derivatives of fatty acids for chromatographic analysis. Advances in lipid methodology-two (1993), Oily Press, Dundee p. 69-111
38. Duvoix A., Delhalle S., Blasius R., Schnekenburger M., Morceau F., Fougere M., et al. Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition. Biochemical Pharmacology 68 (2004) 1101-1111
39. Müller M.M., Schreiber E., Schaffner W., and Matthias P. Rapid test for in vivo stability and DNA-binding of mutated octamer binding-proteins with mini-extracts prepared from transfected cells. Nucleic Acids Research 17 (1989) 6420
40. Abramoff M.D., Magelhaes P.J., and Ram S.J. Image Processing with ImageJ. Biophotonics International 11 (2004) 36-42
41. Folmer F., Blasius R., Morceau F., Tabudravu J., Dicato M., Jaspars M., et al. Inhibition of TNFα-induced activation of nuclear factor κB by kava (Piper methysticum) derivatives. Biochemical Pharmacology 71 (2006) 1206-1218
42. Smith I.R., and Sutherland M.D. Pigments of marine animals. 11. Angular naphthopyrones from crinoid Comanthus parvicirrus Timorensis. Australian Journal of Chemistry 24 (1971) 1487-1489
43. Lv F., Deng Z., Li J., Fu H., van Soest R.W., Proksch P., et al. Isomalabaricane-type compounds from the marine sponge Rhabdastrella aff. distincta. Journal of Natural Products 67 (2004) 2033-2036
44. McCormick J.L., McKee T.C., Cardellina II J.H., Leid M., and Boyd M.R. Cytotoxic triterpenes from a marine sponge, Stelletta sp. Journal of Natural Products 59 (1996) 1047-1050
45. Su J.Y., Meng Y.H., Zeng L.M., Fu X., Schmitz F.J., and Stellettin A. a new triterpenoid pigment from the marine sponge Stelletta tenuis. Journal of Natural Products 57 (1994) 1450-1451
46. Tasdemir D., Mangalindan G.C., Concepcion G.P., Verbitski S.M., Rabindran S., Miranda M., et al. Bioactive isomalabaricane triterpenes from the marine sponge Rhabdastrella globostellata. Journal of Natural Products 65 (2002) 210-214
47. Tabudravu J.N., and Jaspars M. Stelliferin riboside, a triterpene monosaccharide isolated from the Fijian sponge Geodia globostellifera. Journal of Natural Products 64 (2001) 813-815
48. Ravi B.N., and Faulkner D.J. Cembranoid diterpenes from a South Pacific soft coral. Journal of Organic Chemistry 43 (1978) 2127-2131
49. Osterlie M., Bjerkeng B., and Liaaen-Jensen S. Accumulation of astaxanthin all-E, 9Z, and 13Z geometrical isomers and 3 and 3′ R S optical isomers in rainbow trout (Oncorhynchus mykiss) is selective. Journal of Nutrition 129 (1999) 391-398
50. Liu B.H., and Lee Y.K. Composition and biosynthetic pathways of carotenoids in the astaxanthin-producing green alga Chlorococcum sp. Biotechnology Letters 21 (1999) 1007-1010
51. Crews P., Manes L.V., and Boehler M. Jasplakinolide, a cyclodepsipeptide from the marine sponge Jaspis sp. Tetrahedron Letters 27 (1986) 2797-2800
52. Bandaranayake W. The nature and role of pigments of marine invertebrates. Natural Product Reports 23 (2006) 223-255
53. Banerjee D., and Liefshitz A. Potential of the proteasome inhibitor MG-132 as an anticancer agent, alone and in combination. Anticancer Research 21 (2001) 3941-3947
54. Haefner B. NF-kappa B: arresting a major culprit in cancer. Drug Discovery Today 7 (2002) 653-663
55. Greten F.R., and Karin M. The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer. Cancer Letters 206 (2004) 193-199
56. Terracciano S., Rodriquez M., Aquino M., Monti M.C., Casapullo A., Riccio R., et al. Chemistry and biology of anti-inflammatory marine natural products: molecules interfering with cyclo-oxygenase, NF-κB and other unidentified targets. Current Medicinal Chemistry 13 (2006) 1947-1969
57. Haefner B. Drugs from the deep: marine natural products as drug candidates. Drug Discovery Today 8 (2003) 536-544
58. Molinski T., Dalisay D.S., Lievens S.L., and Saludes J.P. Drug development from natural products. Nature Reviews Drug Discovery 8 (2009) 69-85
59. Escoubas J.M., Briant L., Montagnani C., Hez S., Devaux C., and Roch P. Oyster IKK-like protein shares structural and functional properties with its mammalian homologues. FEBS Letters 453 (1999) 293-298
60. Romano G., Russo G.L., Buttino I., Ianora A., and Miralto A. A marine diatom-derived aldehyde induces apoptosis in copepod and sea urchin embryos. Journal of Experimental Biology 206 (2003) 3487-3494
61. Lisowska K., and Witkowski J.M. Viral strategies in modulation of NF-kappaB activity. Archivum Immunologiae et Therapiae Experimentalis 51 (2003) 367-375
62. Hiscott J., Kwon H., and Genin P. Hostile takeovers: viral appropriation of the NF-kappa B pathway. Journal of Clinical Investigation 107 (2001) 143-151
63. Gauthier M.J., and Degnan B.M. The transcription factor NF-kappaB in the demosponge Amphimedon queenslandica: insights on the evolutionary origin of the Rel homology domain. Development Genes and Evolution 218 (2008) 23-32
64. Merlo E., Freudenthal R., and Romano A. The I kappa B kinase inhibitor sulfasalazine impairs long-term memory in the crab Chasmagnathus. Neuroscience 112 (2002) 161-172
65. Povelones M., Tran K., Thanos D., and Ambron R.T. An NF-kappaB-like transcription factor in axoplasm is rapidly inactivated after nerve injury in Aplysia. Journal of Neurosciences 17 (1997) 4915-4920
66. Wang X.W., Tan N.S., Ho B., and Ding J.L. Evidence for the ancient origin of the NF-κB/IκB cascade: its archaic role in pathogen infection and immunity. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 4204-4209
67. Muller W.E., Gamulin V., Rinkevich B., Spreitzer I., Weinblum D., and Schroder H.C. Ubiquitin and ubiquitination in cells from the marine sponge Geodia cydonium. Biological Chemistry Hoppe-Seyler 375 (1994) 53-60
68. Schlezinger J.J., Blickarz C.E., Mann K.K., Doerre S., and Stegeman J.J. Identification of NF-kappaB in the marine fish Stenotomus chrysops and examination of its activation by aryl hydrocarbon receptor agonists. Chemical and Biological Interactions 126 (2000) 137-157
69. Pancer Z., Rast J.P., and Davidson E.H. Origins of immunity: transcription factors and homologues of effector genes of the vertebrate immune system expressed in sea urchin coelomocytes. Immunogenetics 49 (1999) 773-786
70. Colombo M.L., Rise P., Giavarini F., De Angelis L., Galli C., and Bolis C.L. Marine macroalgae as sources of polyunsaturated fatty acids. Plant Foods for Human Nutrition 61 (2006) 67-72
71. Bhakoo M., and Herbert R.A. Fatty acid and phospholipid composition of five psychrotrophic Pseudomonas spp. grown at different temperatures. Archives in Microbiology 126 (1980) 51-55
72. Harwood J., Pettitt T., and Jones A. Lipid metabolism. Biochemistry of algae and cyanobacteria (1988), Oxford University Press, Oxford
73. Pocock T., Lachance M.A., Proeschold T., Priscu J.C., Kim S.S., and Huner N.P.A. Identification of a psychrophilic green alga from Lake Bonney Antarctica: Chlamydomonas raudensis Ettl. (UWO 241) Chlorophyceae. Journal of Phycology 40 (2004) 1138-1148
74. Poerschmann J., Spijkerman E., and Langer U. Fatty acid patterns in Chlamydomonas sp. as a marker for nutritional regimes and temperature under extremely acidic conditions. Microbial Ecology 48 (2004) 78-89
75. Novak T., Babcock T., Jho D., Helton W., and Espat N. NF-kappaB inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. American Journal of Physiology 284 (2003) 84-89
76. Okamoto M., Misunobu F., and Ashida K. Effects of dietary supplementation with omega-3 fatty acids compared with omega-6 fatty acids on bronchial asthma. International Medicine 39 (2000) 107-111
77. Aronson W., Glaspy J., Reddy S., Reese D., Heber D., and Bagga D. Modulation of omega-3/omega-6 polyunsaturated fatty acid ratios with dietary fish oils in men with prostate cancer. Urology 58 (2001) 283-288
78. Cheng W., Lii C., Chen H., Lin T.T., and Liu K. Contribution of conjugated linoleic acid to the suppression of inflammatory responses through the NF-kappaB pathway. Journal of Agricultural and Food Chemistry 52 (2004) 71-78
79. Lee J., Zhao L., Youn H., Weatherill A., Tapping R., Feng L., et al. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. Journal of Biological Chemistry 279 (2004) 16971-16979
80. Mishra A., Chandhary A., and Sethi S. Oxidized omega-3 fatty acids inhibit NF-kappa B activation via a PPARalpha-dependent pathway. Arterosclerosis, thrombosis, and vascular biology 24 (2004) 1621-1627
81. Liu B.H., and Lee Y.K. Effect of total secondary carotenoids extracts from Chlorococcum sp on Helicobacter pylori-infected BALB/c mice. International Immunopharmacology 3 (2003) 979-986
82. Takamatsu S., Hodges T.W., Rajbhandari I., Gerwick W.H., Hamann M.T., and Nagle D.G. Marine natural products as novel antioxidant prototypes. Journal of Natural Products 66 (2003) 605-608
83. Bowie A., and O'Neill L.A. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochemical Pharmacology 59 (2000) 13-23
84. Fedorov S., Radchenko O., Shubina L., Balaneva N., Bode A., Stonik V.A., et al. Evaluation of cancer-preventive activity and structure-activity relationships of 3-demethylubiquinone Q2, isolated from the Ascidian Aplidium glabrum, and its synthetic analogs. Pharmaceutical Research 23 (2006) 70-81
85. Shahidi F., Metusalach B., and Brown J. Carotenoid pigments in seafood and aquaculture. Critical Reviews in Food Science 38 (1998) 1-67
86. Bours V., Bonizzi G., Bentires-Alj M., Bureau F., Piette J., Lekeux P., et al. NF-kappaB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment. Toxicology 153 (2000) 27-38
87. Shrivastava A., and Aggarwal B.B. Antioxidants differentially regulate activation of nuclear factor-κB, activator protein-1, c-Jun amino-terminal kinases, and apopoptosis induced by tumor necrosis factor: evidence that JNK and NF-κB activation are not linked to apoptosis. Antioxidants & Redox Signaling 1 (1999) 181-191